XARELTO® (rivaroxaban): Summary

XARELTO® (rivaroxaban)

Healthcare, Pharmaceuticals, Anticoagulants, Prescription Medications

XARELTO® provides effective management of blood clot risks, enhancing patient safety and health outcomes.

XARELTO® is a prescription medication used to prevent and treat blood clots and reduce the risk of stroke in patients with certain medical conditions. It works by inhibiting Factor Xa, an enzyme crucial for blood clotting.

Reduces the risk of stroke and blood clots in patients with atrial fibrillation.; Treats and prevents deep vein thrombosis (DVT) and pulmonary embolism (PE).; Can be used in conjunction with low-dose aspirin for additional heart protection.; Available for both adults and children, with specific dosing guidelines.

Preventing strokes in patients with atrial fibrillation.; Treating and preventing blood clots in patients post-surgery.; Managing blood clot risks in hospitalized patients.; Providing anticoagulation therapy for children with specific conditions.

Proven track record with over 80 million prescriptions in the US.; Comprehensive support options for cost management.; Wide range of indications, including use in both adults and children.

XARELTO® is well-supported by clinical evidence, has a broad range of applications, and offers patient support resources to help manage costs.

XARELTO® positions itself as a leading anticoagulant with a strong safety profile and extensive clinical backing.

The primary target users include adults with atrial fibrillation, patients recovering from surgery, and children with congenital heart conditions.

Janssen Pharmaceuticals, the manufacturer, emphasizes trust and reliability in healthcare, focusing on patient safety and comprehensive support.

Get help identifying cost support options that may help with managing your out-of-pocket cost for XARELTO®.

XARELTO® is unique in its ability to be prescribed for a wide range of conditions, including use in children, and its specific mechanism of action targeting Factor Xa.

XARELTO® has been prescribed more than 80 million times in the US alone.

• anticoagulant

• blood clots

• stroke prevention

• patient support

Informative, supportive, reassuring